Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | POLA1 | P09884 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11862242 | 1.00 | TSHR (0.64) | TSHRLMNAALDH1A1KMT2ARECQL | |
| SCHEMBL11860832 | 1.00 | TSHR (0.64) | TSHRLMNAALDH1A1KMT2ARECQL | |
| SCHEMBL1365915 | 1.00 | TSHR (0.64) | TSHRLMNAALDH1A1KMT2ARECQL | |
| SCHEMBL1363303 | 1.00 | TSHR (0.64) | TSHRLMNAALDH1A1KMT2ARECQL | |
| SCHEMBL328762 | 1.00 | TSHR (0.64) | TSHRLMNAALDH1A1KMT2ARECQL | |
| SCHEMBL1363541 | 0.98 | — | — | |
| SCHEMBL83390 | 0.90 | — | — | |
| SCHEMBL11432928 | 0.88 | ALDH1A1 (0.59) | TSHRLMNAALDH1A1RECQLFAAH | |
| SCHEMBL11432924 | 0.88 | ALDH1A1 (0.59) | TSHRLMNAALDH1A1RECQLFAAH | |
| SCHEMBL25824485 | 0.88 | TSHR (0.50) | TSHRLMNAALDH1A1KMT2ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119371328-A | Preparation method of 8-amino octanoic acid | 苏州昊帆生物股份有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119371328-A | Preparation method of 8-amino octanoic acid | 苏州昊帆生物股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-9957217-B2 | Conversion of alcohols to carboxylic acids using heterogeneous palladium-based catalysts | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2018-05-01 | — | — | US | disclosed |
| US-20170137362-A1 | CONVERSION OF ALCOHOLS TO CARBOXYLIC ACIDS USING HETEROGENEOUS PALLADIUM-BASED CATALYSTS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2017-05-18 | — | — | US | disclosed |
| US-9593064-B2 | Conversion of alcohols to alkyl esters and carboxylic acids using heterogeneous palladium-based catalysts | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-03-14 | — | — | US | disclosed |
| CN-103896860-B | Irreversible EGFR inhibitor containing zinc binding moiety | TONGHUA JIDA PHARMACEUTICAL CO., LTD. (CN) | 2016-02-17 | — | — | CN | disclosed |
| US-20150314272-A1 | Conversion Of Alcohols To Alkyl Esters And Carboxylic Acids Using Heterogeneous Palladium-Based Catalysts | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2015-11-05 | — | — | US | disclosed |
| CN-103896860-A | Zinc binding group-containing irreversible EGFR inhibitors | TONGHUAJIDA MEDICINE CO LTD | 2014-07-02 | — | — | CN | disclosed |
| US-8067136-B2 | Charge control agent, toner, image forming method, and image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2011-11-29 | — | — | US | disclosed |
| US-7589156-B2 | Polyhydroxyalkanoic acid having ester, carboxyl or sulfonic acid group, and producing method therefor | CANON KABUSHIKI KAISHA (JP) | 2009-09-15 | — | — | US | disclosed |
| EP-1774410-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | Canon Kabushiki Kaisha (JP) | 2007-04-18 | — | — | EP | disclosed |
| US-20070073006-A1 | Polyhydroxyalkanoate having vinyl group, ester group, carboxyl group, and sulfonic group, and method of producing the same | CANON KABUSHIKI KAISHA (JP) | 2007-03-29 | — | — | US | disclosed |
| EP-1758948-A2 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | Canon Kabushiki Kaisha (JP) | 2007-03-07 | — | — | EP | disclosed |
| US-20060194071-A1 | Developer carrying member and development apparatus | CANON KABUSHIKI KAISHA (JP) | 2006-08-31 | — | — | US | disclosed |
| US-20050287484-A1 | Resin-coated carrier for electrophotographic developer | CANON KABUSHIKI KAISHA (JP) | 2005-12-29 | — | — | US | disclosed |
| WO-2005121204-A2 | POLYHYDROXYALKANOIC ACID HAVING VINYL, ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121207-A2 | POLYHYDROXYALKANOATE HAVING VINYL GROUP, ESTER GROUP, CARBOXYL GROUP, AND SULFONIC GROUP, AND METHOD OF PRODUCING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121904-A1 | CHARGE CONTROL AGENT, TONER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121208-A1 | POLYHYDROXYALKANOIC ACID HAVING ESTER, CARBOXYL OR SULFONIC ACID GROUP AND PRODUCING METHOD THEREFOR | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
| WO-2005121205-A2 | POLYHYDROXYALKANOATE HAVING ESTER GROUP, CABOXYL GROUP, AND SULFONIC GROUP, AND METHOD OF PRODUCING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150314272-A1 | Conversion Of Alcohols To Alkyl Esters And Carboxylic Acids Using Heterogeneous Palladium-Based Catalysts | ADH5, ADH1A, ADH1C | TSHR 683/4885LMNA 4407/4885ALDH1A1 391/4885 |
| US-20170137362-A1 | CONVERSION OF ALCOHOLS TO CARBOXYLIC ACIDS USING HETEROGENEOUS PALLADIUM-BASED CATALYSTS | ADH5, ADH1A, ADH1C | TSHR 903/4885LMNA 4586/4885ALDH1A1 296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.